Trending Now
Centessa Pharmaceuticals Plc (NASDAQ: CNTA) and Z factor Limited Announce Proof-of-Mechanism...
Centessa Pharmaceuticals Plc (NASDAQ: CNTA) and its subsidiary Z Factor Limited have announced proof-of-mechanism results from the first three participants dosed in the current...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Mustang Bio Inc. (NASDAQ:MBIO) Signs Technology Transfer and GMP Manufacturing Deal...
Mustang Bio Inc. (NASDAQ:MBIO) and Minaris Regenerative Medicine GmBH have entered an agreement for technology transfer and GMP clinical manufacturing of MB-107. MB-107 is...
MAKE IT MODERN
LATEST REVIEWS
Sorrento Therapeutics Inc. (NASDAQ: SRNE) Commences Phase 2 Study Enrolment Evaluating...
Sorrento Therapeutics Inc. (NASDAQ: SRNE) has announced the commencement of enrolment in its second phase efficacy trial of human allogeneic adipose-derived mesenchymal stem cells...
MAKE IT MODERN
PERFORMANCE TRAINING
Trillium Therapeutics Inc. (NASDAQ:TRIL) Reports Q3 2020 Financial and Program Updates on TTI-621 and...
Trillium Therapeutics Inc. (NASDAQ:TRIL) has announced its operating and financial results for the three months and nine months ended September 30, 2020.
The company's CEO...
MEIP Stock sees a Significant Surge Amidst Strategic Evaluation
Shares of MEI Pharma, Inc. (NASDAQ: MEIP) experienced a remarkable 21.33% increase today, closing at $3.47. The momentum continued after hours, with...
AVEO Oncology (NASDAQ:AVEO) Announce Publication Of Phase 3 TIVO-3 Study Data In European Urology...
AVEO Oncology (NASDAQ:AVEO) has announced the final overall survival data from the Phase 3 TIVO-3 Study in the European Urology journal.
AVEO publishes TIVI-3 study...
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) Issued Its Shareholders and Investors With an Update...
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) recently declared that Dr Frederike Holze and Dr Matthias Lietchi would be the person to give an update...
Cassava Sciences Inc. (NASDAQ: SAVA) Launches New Clinical Website Offering Information On Sumifilam Study...
Cassava Sciences Inc. (NASDAQ: SAVA) has launched a new clinical website called www.Rethink-ALZ.com meant to offer access, information, and visibility about the company's third...
MAKE IT MODERN
